malondialdehyde has been researched along with Parkinson Disease in 65 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (3.08) | 18.7374 |
| 1990's | 6 (9.23) | 18.2507 |
| 2000's | 14 (21.54) | 29.6817 |
| 2010's | 30 (46.15) | 24.3611 |
| 2020's | 13 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, J; Guo, L; Li, W; Li, Y; Qiu, J; Wang, L; Zhang, T | 1 |
| Mohajeri, D; Nourazar, MA; Sokouti, H | 1 |
| Dolrahman, N; Mukkhaphrom, W; Sutirek, J; Thong-Asa, W | 1 |
| Albalawi, MA; Alzlaiq, WA; Atif, HM; Bilasy, SE; Eladl, MA; Elaidy, SM; ElSayed, MH; Farag, NE; Helal, MA; Helaly, AMN; Hisham, FA; Ibrahiem, AT; Khella, HWZ; Osman, NMS; Zaitone, SA | 1 |
| Bilal, B; Erbas, O; Erdogan, MA; Kirazlar, M; Yigitturk, G | 1 |
| Fu, J; Gao, X; Liu, S; Lu, F; Lu, Y; Mohammed, SAD; Nan, Y; Wang, T; Wang, Y | 1 |
| Deng, Y; Ke, M; Wu, H; Xie, B | 1 |
| Abolhassani, M; Juybari, KB; Mehrabani, M; Mirzamohammadi, S; Nematollahi, MH; Paseban, H; Saravani, M; Sharifi, AM; Tarzi, ME | 1 |
| Araujo, SM; Bortolotto, VC; Dahleh, MMM; de Freitas Couto, S; Jardim, EF; Meichtry, LB; Musachio, EAS; Petri Guerra, G; Poetini, MR; Prigol, M; Ramborger, BP; Roehrs, R | 1 |
| Jiang, X; Qiao, B; Yue, Y | 1 |
| Liu, L; Wang, H; Wang, J | 1 |
| Ishiguro, T; Itoh, T; Kaba, N; Tsuda, S; Umemoto, H; Yasugi, S; Yoda, M | 1 |
| Ahmad, B; Bibi, S; Chauhdary, Z; Raza, Z; Saleem, U; Shah, MA; Shah, S; Shehzad, A | 1 |
| Gao, Z; Liu, Y; Shen, L; Wang, Z | 1 |
| Ju, B; Li, JF; Liu, YJ; Wang, HT; Wang, SS; Wang, YL; Yang, XP; Yin, HL; Zeng, ZL; Zhang, YZ | 1 |
| Drakulić, D; Ilić, TV; Miletić, J; Miljković, M; Pejić, S; Petković, M; Prostran, M; Stefanović, A; Stojanov, M | 1 |
| Dai, L; Kuang, S; Li, J; Rao, Z; Tang, X; Yang, L; Zhong, H; Zhong, Z | 1 |
| Babayan-Tazehkand, A; Dargahi, T; Haghdoost-Yazdi, H; Rastgoo, N; Sarbazi Golezari, A; Sarukhani, M | 1 |
| Gong, J; Li, X; Liu, YY; Xia, XJ; Yang, QS; Zhang, L; Zhang, Q | 1 |
| Carro, E; De la Fuente, M; Garrido, A; Kobayashi, H; Martínez de Toda, I; Molina, JA; Vida, C | 1 |
| Ansari, SA; Azimullah, S; Javed, H; Meeran, MFN; Ojha, S | 1 |
| Adem, A; Azimullah, S; Beiram, R; Jalal, FY; Jayaraj, RL; Meeran, MFN; Ojha, SK | 1 |
| Bhattacharya, R; Kaushal, M; Lomash, V; Satpute, R | 1 |
| Ciobica, A; Hritcu, L | 1 |
| Ding, QF; Liu, CB; Lu, FB; Pan, HB; Wang, R | 1 |
| Bao, Q; Feng, G; Jiang, J; Li, S; Zhang, Z; Zhou, L | 1 |
| Borgohain, R; Devi, YP; Kumudini, N; Kutala, VK; Mridula, R; Naushad, SM; Uma, A | 1 |
| Li, J; Li, X; Wang, LN; Xiao, HL; Yang, JJ | 1 |
| An, D; Li, SL; Peng, Y; Sun, YP; Wang, DM; Xu, H; Yin, SM; Yu, DQ; Zhang, WQ; Zhao, D; Zhao, J | 1 |
| Cruickshank, TM; Reyes, AR; Ziman, MR | 1 |
| Hu, R; Li, K; Li, X; Lu, C; Wang, Y; Wei, Y | 1 |
| Chen, C; Fan, Q; Huang, J; Pan, X; Wei, H | 1 |
| Baluchnejadmojarad, T; Kiasalari, Z; Roghani, M | 1 |
| Cui, Q; Li, X; Zhu, H | 1 |
| Qi, Z; Tong, Q; Yuan, Y; Zhang, K; Zhou, H | 1 |
| Dolatshahi, M; Farbood, Y; Khodadadi, A; Mansouri, SM; Sarkaki, A | 1 |
| Ataç Uçar, C; Aytaç, B; Çubukçu, HC; Durak, İ; Durak, ZE; Gökçe Çokal, B; Güneş, HN; Keskin Güler, S; Yoldaş, TK; Yurtdaş, M | 1 |
| Baluchnejadmojarad, T; Rabiee, N; Roghani, M; Zabihnejad, S | 1 |
| Bloomer, RJ; Callegari, J; Karlage, RE; Ledoux, MS; Pfeiffer, RF; Schilling, BK | 1 |
| Chen, P; Chen, Z; Li, A; Liang, LP; Lou, XC; Wang, SL; Wu, XK; Zhao, CJ | 1 |
| Alam, MM; Anwer, T; Azam, F; Barodia, SK | 1 |
| Chen, CM; Chen, YC; Cheng, HS; Cheng, ML; Chiu, DT; Liu, JL; Wu, YR | 1 |
| Ahmed, MA; Alkskas, IA; Azam, F | 1 |
| Beal, MF; Calingasan, NY; Cormier, K; Ferrante, RJ; Smith, K; Wille, EJ; Yang, L | 1 |
| Hirai, K; Ono, S; Tokuda, E | 1 |
| Bach, JH; Bing, G; Jin, CH; Jung, BD; Kim, HC; Nah, SY; Nguyen, XK; Park, SJ; Shin, EJ; Wie, MB | 1 |
| Ferrer, I; Gomez, A | 1 |
| Kuo, WW; Liu, WH; Tsai, SJ; Yin, MC | 1 |
| An, L; Dong, W; Dong, Y; Liu, S; Tang, B | 1 |
| Li, S; Pu, XP | 1 |
| Ayala, V; Dalfó, E; Ferrer, I; Martínez, A; Pamplona, R; Portero-Otín, M | 1 |
| Moreira, PI; Perry, G; Sayre, LM; Smith, MA | 1 |
| Barthwal, MK; Dikshit, M; Rajani, M; Shukla, R; Srivastava, N | 1 |
| Gill, KD; Kaur, P; Kumar, B; Prabhakar, S; Sharma, A | 1 |
| Hou, CY; Kou, ST; Pu, ZH; Tian, YP; Xie, XX | 1 |
| Kerk, S; Meng Lim, T; Zhou, Z | 1 |
| Deng, YL; Liu, XQ; Qing, H; Wang, R; Zheng, XL | 1 |
| Cooper, JM; Harley, A; Schapira, AH | 1 |
| Ahlskog, JE; Kokmen, E; Low, PA; Nickander, KK; Petersen, RC; Tyce, GM; Uitti, RJ | 1 |
| Ahlskog, JE; Low, PA; Nickander, KK; O'Brien, JF; Tyce, GM; Uitti, RJ | 1 |
| Arencibia, R; Broche, F; Castellano, O; Céspedes, EM; García, JC; Gómez, AA; González-Fraguela, ME | 1 |
| Chaudhary, AK; Kalra, J; Mantha, SV; Prasad, K; Rajput, AH | 1 |
| Codoceo, R; Fernandez-Calle, P; Jiménez-Jiménez, FJ; Lalinde, L; Molina, JA; Pondal, M; Tenias, JM; Vazquez, A | 1 |
| Agid, F; Agid, Y; Carter, C; Dexter, D; Jenner, P; Lees, AJ; Marsden, CD | 1 |
| Agid, Y; Carter, CJ; Dexter, DT; Javoy-Agid, F; Jenner, P; Lees, A; Marsden, CD; Wells, FR | 1 |
2 review(s) available for malondialdehyde and Parkinson Disease
| Article | Year |
|---|---|
A systematic review and meta-analysis of strength training in individuals with multiple sclerosis or Parkinson disease.
Topics: Biomarkers; Disease Progression; Electromyography; Fatigue; Glutathione Peroxidase; Humans; Hydrogen Peroxide; Malondialdehyde; Mobility Limitation; Multiple Sclerosis; Muscle Strength; Parkinson Disease; Postural Balance; Quality of Life; Resistance Training; Superoxide Dismutase | 2015 |
Metal ions and oxidative protein modification in neurological disease.
Topics: Aldehydes; alpha-Synuclein; Alzheimer Disease; Animals; Cross-Linking Reagents; Encephalomyelitis, Autoimmune, Experimental; Free Radicals; Glycation End Products, Advanced; Humans; Lipid Peroxidation; Malondialdehyde; Metals; Mice; Multiple Sclerosis; Neurodegenerative Diseases; Oxidation-Reduction; Oxidative Stress; Parkinson Disease; Proteins; Rats; Reactive Oxygen Species | 2005 |
2 trial(s) available for malondialdehyde and Parkinson Disease
| Article | Year |
|---|---|
Effect of resistance training on blood oxidative stress in Parkinson disease.
Topics: Biomarkers; Female; Humans; Hydrogen Peroxide; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Parkinson Disease; Resistance Training | 2008 |
[Indicators of oxidative stress and the effect of antioxidant treatment in patients with primary Parkinson disease].
Topics: Antioxidants; Ascorbic Acid; Biomarkers; Catalase; Disease Progression; Humans; Malondialdehyde; Monoamine Oxidase Inhibitors; Oxidative Stress; Parkinson Disease; Phospholipases A; Phospholipases A2; Reactive Oxygen Species; Spectrophotometry; Vitamin E | 1998 |
61 other study(ies) available for malondialdehyde and Parkinson Disease
| Article | Year |
|---|---|
Shikonin ameliorates oxidative stress and neuroinflammation via the Akt/ERK/JNK/NF-κB signalling pathways in a model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cyclooxygenase 2; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Glutathione; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Malondialdehyde; Mice; Mice, Inbred C57BL; Naphthoquinones; Neuroinflammatory Diseases; Neurotoxins; NF-kappa B; Nitric Oxide Synthase Type II; Oxidative Stress; Parkinson Disease; Proto-Oncogene Proteins c-akt; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Tyrosine 3-Monooxygenase | 2022 |
6-Hydroxydopamine-Induced Neurotoxicity in Rat Model of Parkinson's Disease: Is Reversed via Anti-Oxidative Activities of Curcumin and Aerobic Exercise Therapy.
Topics: alpha-Synuclein; Animals; Antioxidants; Apomorphine; Curcumin; Disease Models, Animal; Glutathione Peroxidase; Malondialdehyde; Neuroprotective Agents; Neurotoxicity Syndromes; Neurotoxins; Oxidopamine; Parkinson Disease; Rats; Substantia Nigra | 2022 |
Benefits of p-coumaric acid in mice with rotenone-induced neurodegeneration.
Topics: Animals; Disease Models, Animal; Dopaminergic Neurons; Male; Malondialdehyde; Mice; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Rotenone; Tumor Necrosis Factor-alpha | 2023 |
Betanin improves motor function and alleviates experimental Parkinsonism via downregulation of TLR4/MyD88/NF-κB pathway: Molecular docking and biological investigations.
Topics: Animals; Betacyanins; Down-Regulation; Male; Malondialdehyde; Mice; Molecular Docking Simulation; Myeloid Differentiation Factor 88; NF-kappa B; Parkinson Disease; Parkinsonian Disorders; Rotenone; Toll-Like Receptor 4 | 2023 |
Lacosamide exhibits neuroprotective effects in a rat model of Parkinson's disease.
Topics: Animals; Apomorphine; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Lacosamide; Male; Malondialdehyde; Mice; Neuroprotective Agents; Parkinson Disease; Rats; Rats, Sprague-Dawley; Rotenone; Substantia Nigra; Tumor Necrosis Factor-alpha | 2023 |
Efficacy and mechanism study of Baichanting compound, a combination of Acanthopanax senticosus (Rupr. and Maxim.) Harms, Paeonia lactiflora Pall and Uncaria rhynchophylla (Miq.) Miq. ex Havil, on Parkinson's disease based on metagenomics and metabolomics.
Topics: Animals; Antioxidants; Chromatography, Liquid; Dopamine; Eleutherococcus; Glutamic Acid; Glutamine; Interleukin-6; Malondialdehyde; Metabolomics; Mice; Mice, Inbred C57BL; Paeonia; Parkinson Disease; Superoxide Dismutase; Tandem Mass Spectrometry; Tumor Necrosis Factor-alpha | 2024 |
High-fat diet causes increased endogenous neurotoxins and phenotype of Parkinson's disease in mice.
Topics: Animals; Diabetes Mellitus, Type 2; Diet, High-Fat; Glucose Intolerance; Isoquinolines; Malondialdehyde; Mice; Neurotoxins; Parkinson Disease; Salsoline Alkaloids | 2019 |
Protective effect of hydralazine on a cellular model of Parkinson's disease: a possible role of hypoxia-inducible factor (HIF)-1α.
Topics: Antioxidants; Apoptosis; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Dopamine; Humans; Hydralazine; Hypoxia-Inducible Factor 1, alpha Subunit; Malondialdehyde; Nitric Oxide; Oxidopamine; Parkinson Disease; Superoxide Dismutase | 2020 |
Bisphenol A exposure is involved in the development of Parkinson like disease in Drosophila melanogaster.
Topics: Animals; Benzhydryl Compounds; Catalase; Disease Models, Animal; Dopamine; Drosophila melanogaster; Drosophila Proteins; Female; Glutathione Transferase; Humans; Male; Malondialdehyde; Mitochondria; No-Observed-Adverse-Effect Level; Oxidative Stress; Parkinson Disease; Phenols; Reactive Oxygen Species; Superoxide Dismutase | 2020 |
Tormentic acid confers protection against oxidative stress injury in rats with Parkinson's disease by targeting the Wnt/β-catenin signaling pathway.
Topics: Animals; Behavior, Animal; Cell Survival; Female; Glutathione Peroxidase; Male; Malondialdehyde; Memory; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease; PC12 Cells; Rats; Rats, Wistar; RNA, Messenger; Superoxide Dismutase; Triterpenes; Wnt Signaling Pathway | 2020 |
Hydrogen sulfide alleviates oxidative stress injury and reduces apoptosis induced by MPP
Topics: 1-Methyl-4-phenylpyridinium; Apoptosis; Caspase 3; Cell Survival; Gasotransmitters; Herbicides; Humans; Hydrogen Sulfide; Malondialdehyde; Neuroblastoma; Nitric Oxide Synthase Type II; Oxidative Stress; Parkinson Disease; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Signal Transduction; Superoxide Dismutase; Tumor Cells, Cultured | 2020 |
Protective Effect of Nervonic Acid Against 6-Hydroxydopamine-Induced Oxidative Stress in PC-12 Cells.
Topics: Animals; Antioxidants; Brain; Cell Membrane; Cell Survival; Fatty Acids, Monounsaturated; Glutamate-Cysteine Ligase; Glutathione; Lipid Bilayers; Lipid Peroxidation; Malondialdehyde; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease; PC12 Cells; Rats; Superoxide Dismutase | 2021 |
Antiparkinsonian activity of Cucurbita pepo seeds along with possible underlying mechanism.
Topics: Animals; Antioxidants; Antiparkinson Agents; Cucurbita; Malondialdehyde; Parkinson Disease; Plant Extracts; Rats; Superoxide Dismutase | 2021 |
The Relationship between Levels of Serum Metal Ions and Parkinson's Disease.
Topics: Humans; Ions; Malondialdehyde; Parkinson Disease; Substantia Nigra; Superoxide Dismutase | 2021 |
Protective Effect of Curcumin Against Oxidative Stress-Induced Injury in Rats with Parkinson's Disease Through the Wnt/ β-Catenin Signaling Pathway.
Topics: Animals; Apoptosis; Astrocytes; Behavior, Animal; beta Catenin; Cell Adhesion; Cells, Cultured; Curcumin; Cyclin D1; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Glial Fibrillary Acidic Protein; Glutathione Peroxidase; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Male; Malondialdehyde; Membrane Potential, Mitochondrial; Oxidative Stress; Oxidopamine; Parkinson Disease; Protective Agents; Proto-Oncogene Proteins c-myc; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Tyrosine 3-Monooxygenase; Wnt Signaling Pathway; Wnt3 Protein | 2017 |
Prooxidant-antioxidant balance, advanced oxidation protein products and lipid peroxidation in Serbian patients with Parkinson's disease.
Topics: Adult; Advanced Oxidation Protein Products; Aged; Aged, 80 and over; Aldehydes; Antioxidants; Female; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidants; Parkinson Disease; Serbia; Severity of Illness Index; Statistics, Nonparametric | 2018 |
Effects of Ginkgo Biloba Extract on A53T α-Synuclein Transgenic Mouse Models of Parkinson's Disease.
Topics: Alanine; alpha-Synuclein; Animals; Antiparkinson Agents; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Ginkgo biloba; Glutathione; Glutathione Peroxidase; Locomotion; Malondialdehyde; Mice; Mice, Transgenic; Muscle Strength; Mutation; Parkinson Disease; Plant Extracts; Superoxide Dismutase; Swimming; Threonine | 2018 |
Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.
Topics: Analysis of Variance; Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Glutathione Peroxidase; Hydrogen Sulfide; Male; Malondialdehyde; Motor Activity; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Postural Balance; Rats; Rats, Wistar; Rotarod Performance Test; Superoxide Dismutase; Sympatholytics | 2018 |
Lentiviral Vector-Mediated SHC3 Silencing Exacerbates Oxidative Stress Injury in Nigral Dopamine Neurons by Regulating the PI3K-AKT-FoxO Signaling Pathway in Rats with Parkinson's Disease.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Dopaminergic Neurons; Forkhead Transcription Factors; Lentivirus; Male; Malondialdehyde; Oxidative Stress; Parkinson Disease; PC12 Cells; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; RNA Interference; RNA, Small Interfering; Signal Transduction; Src Homology 2 Domain-Containing, Transforming Protein 3; Superoxide Dismutase | 2018 |
Lymphoproliferation Impairment and Oxidative Stress in Blood Cells from Early Parkinson's Disease Patients.
Topics: Adult; Aged; Biomarkers; Blood Cells; Cell Proliferation; Cross-Sectional Studies; Female; Glutathione; Glutathione Peroxidase; Humans; Lymphocytes; Male; Malondialdehyde; Neutrophils; Oxidation-Reduction; Oxidative Stress; Parkinson Disease | 2019 |
Neuroprotective Effects of Thymol, a Dietary Monoterpene Against Dopaminergic Neurodegeneration in Rotenone-Induced Rat Model of Parkinson's Disease.
Topics: Animals; Catalase; Cyclooxygenase 2; Cytokines; Diet; Disease Models, Animal; Dopaminergic Neurons; Glutathione; Inflammation Mediators; Lipid Peroxidation; Male; Malondialdehyde; Neostriatum; Nerve Degeneration; Neuroglia; Neuroprotective Agents; Nitric Oxide Synthase Type II; Parkinson Disease; Rats, Wistar; Rotenone; Substantia Nigra; Superoxide Dismutase; Thymol; Tyrosine 3-Monooxygenase | 2019 |
Lycopodium Attenuates Loss of Dopaminergic Neurons by Suppressing Oxidative Stress and Neuroinflammation in a Rat Model of Parkinson's Disease.
Topics: alpha-Synuclein; Animals; Antioxidants; Brain; Catalase; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Dopaminergic Neurons; Glutathione; Inflammation; Inflammation Mediators; Lipid Peroxidation; Lycopodium; Male; Malondialdehyde; Matrix Metalloproteinases; Microglia; Nerve Degeneration; Neuroprotection; Nitric Oxide; Nitric Oxide Synthase Type II; Nitrites; Oxidative Stress; Parkinson Disease; Plant Extracts; Rats, Wistar; Rotenone; Superoxide Dismutase | 2019 |
Neuroprotective effects of α-ketoglutarate and ethyl pyruvate against motor dysfunction and oxidative changes caused by repeated 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine exposure in mice.
Topics: Animals; Antioxidants; Electron Transport Complex I; Glutathione; Ketoglutaric Acids; Male; Malondialdehyde; Mice; MPTP Poisoning; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Peroxidase; Psychomotor Performance; Pyruvates; Superoxide Dismutase | 2013 |
Intranigral lipopolysaccharide administration induced behavioral deficits and oxidative stress damage in laboratory rats: relevance for Parkinson's disease.
Topics: Animals; Behavior, Animal; Glutathione Peroxidase; Hippocampus; Lipid Peroxidation; Lipopolysaccharides; Male; Malondialdehyde; Maze Learning; Memory; Microinjections; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Pergolide; Rats; Rats, Wistar; Rotation; Substantia Nigra; Superoxide Dismutase; Temporal Lobe | 2013 |
[Effect of lycopene on oxidative stress and behavioral deficits in rotenone induced model of Parkinson's disease].
Topics: Animals; Behavior, Animal; Brain; Carotenoids; Disease Models, Animal; Dopamine; Lycopene; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Neurons; Oxidative Stress; Parkinson Disease; Rotenone; Superoxide Dismutase | 2013 |
Protective effect of chinonin in MPTP-induced C57BL/6 mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Gait; Glutathione; Homovanillic Acid; Male; Malondialdehyde; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Neurotoxins; Parkinson Disease; Substantia Nigra; Superoxide Dismutase; Xanthones | 2014 |
Association of Parkinson's disease with altered serum levels of lead and transition metals among South Indian subjects.
Topics: Case-Control Studies; Copper; Female; Humans; India; Iron; Lead; Male; Malondialdehyde; Manganese; Mass Spectrometry; Middle Aged; Oxidative Stress; Parkinson Disease; Transition Elements | 2014 |
[Effect of electroacupuncture intervention on levels of SOD, GSH, GSH-Px, MDA, and apoptosis of dopaminergic neurons in substantia Nigra in rats with Parkinson's disease].
Topics: Animals; Apoptosis; Dopaminergic Neurons; Electroacupuncture; Glutathione; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Oxidative Stress; Parkinson Disease; Rats; Substantia Nigra; Superoxides | 2014 |
Neuroprotection by scorpion venom heat resistant peptide in 6-hydroxydopamine rat model of early-stage Parkinson's disease.
Topics: Animals; Antioxidants; Corpus Striatum; Disease Models, Animal; Dopaminergic Neurons; Malondialdehyde; Mesencephalon; Mitochondria; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease; Peptides; Rats; Rats, Sprague-Dawley; Scorpion Venoms; Superoxide Dismutase | 2014 |
Transcranial Direct Current Stimulation Ameliorates Behavioral Deficits and Reduces Oxidative Stress in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Mouse Model of Parkinson's Disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Disease Models, Animal; Dopamine; Glutathione Peroxidase; Male; Malondialdehyde; Mental Disorders; Mice; Mice, Inbred C57BL; Oxidative Stress; Parkinson Disease; Psychomotor Performance; Superoxide Dismutase; Transcranial Direct Current Stimulation; Tyrosine 3-Monooxygenase | 2015 |
Neuroprotective effect of combined therapy with hyperbaric oxygen and madopar on 6-hydroxydopamine-induced Parkinson's disease in rats.
Topics: Animals; Apomorphine; Benserazide; Combined Modality Therapy; Drug Combinations; Glial Fibrillary Acidic Protein; Glutathione Peroxidase; Hyperbaric Oxygenation; Levodopa; Lipid Peroxidation; Male; Malondialdehyde; Nerve Degeneration; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-bcl-2; Rats, Wistar; Stereotyped Behavior; Substantia Nigra; Superoxide Dismutase; Tyrosine 3-Monooxygenase | 2015 |
Hypericum Perforatum Hydroalcoholic Extract Mitigates Motor Dysfunction and is Neuroprotective in Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson's Disease.
Topics: Animals; Apomorphine; Catalase; Corpus Striatum; Disease Models, Animal; Ethanol; Glutathione; Hypericum; Male; Malondialdehyde; Mitogen-Activated Protein Kinases; Motor Activity; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Plant Extracts; Rats, Wistar; Reaction Time; Tumor Necrosis Factor-alpha; Tyrosine 3-Monooxygenase; Water | 2016 |
Curcumin ameliorates dopaminergic neuronal oxidative damage via activation of the Akt/Nrf2 pathway.
Topics: Animals; Antioxidants; Chromones; Curcumin; Dopaminergic Neurons; Glutathione; HEK293 Cells; Humans; Male; Malondialdehyde; Morpholines; Neuroprotection; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Parkinson Disease; Proto-Oncogene Proteins c-akt; Rats, Inbred Lew; Reactive Oxygen Species; RNA, Small Interfering; Rotenone | 2016 |
[Study on changes of plasma levels of oxidative stress biomarkers and its relation with cognition function in patients with parkinson's disease].
Topics: Antioxidants; Biomarkers; Catalase; Cognition; Cognition Disorders; Female; Glutathione; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Oxidative Stress; Parkinson Disease; Superoxide Dismutase | 2015 |
Neuroprotective Effects of Ellagic Acid in a Rat Model of Parkinson's Disease.
Topics: Animals; Antioxidants; Brain; Corpus Striatum; Ellagic Acid; Glutathione Peroxidase; Male; Malondialdehyde; Medial Forebrain Bundle; Models, Animal; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar | 2016 |
Serum glutathione peroxidase, xanthine oxidase, and superoxide dismutase activities and malondialdehyde levels in patients with Parkinson's disease.
Topics: Aged; Antioxidants; Female; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Middle Aged; Oxidants; Oxidation-Reduction; Oxidative Stress; Parkinson Disease; Superoxide Dismutase; Xanthine Oxidase | 2017 |
Ellagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of Parkinson's disease: Possible involvement of ERβ/Nrf2/HO-1 signaling.
Topics: Animals; Antioxidants; Apoptosis; Corpus Striatum; Dopaminergic Neurons; Ellagic Acid; Estrogen Receptor beta; Heme Oxygenase (Decyclizing); Malondialdehyde; Models, Animal; Monoamine Oxidase; Neostriatum; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Oxidopamine; Parkinson Disease; Pars Compacta; Rats; Reactive Oxygen Species; Signal Transduction; Substantia Nigra | 2017 |
Catalytic metalloporphyrin protects against paraquat neurotoxicity in vivo.
Topics: Animals; Antioxidants; Antiparkinson Agents; Behavior, Animal; Catalysis; Corpus Striatum; Dopamine; Male; Malondialdehyde; Metalloporphyrins; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Paraquat; Parkinson Disease; Substantia Nigra; Tyrosine 3-Monooxygenase | 2008 |
Neuroprotective effect of naphtha[1,2-d]thiazol-2-amine in an animal model of Parkinson's disease.
Topics: Animals; Antioxidants; Brain; Catalepsy; Disease Models, Animal; Dose-Response Relationship, Drug; Glutathione; Glutathione Peroxidase; Haloperidol; Male; Malondialdehyde; Mice; Naphthalenes; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Superoxide Dismutase; Thiazoles | 2009 |
Increased oxidative damage in peripheral blood correlates with severity of Parkinson's disease.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Analysis of Variance; Blood Chemical Analysis; Chromatography, High Pressure Liquid; Deoxyguanosine; Erythrocytes; Female; Glutathione Peroxidase; Humans; Leukocytes; Logistic Models; Male; Malondialdehyde; Oxidative Stress; Parkinson Disease; Risk Factors; Vitamin E | 2009 |
Synthesis of some urea and thiourea derivatives of 3-phenyl/ethyl-2-thioxo-2,3-dihydrothiazolo[4,5-d]pyrimidine and their antagonistic effects on haloperidol-induced catalepsy and oxidative stress in mice.
Topics: Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Brain; Catalepsy; Glutathione; Glutathione Peroxidase; Haloperidol; Male; Malondialdehyde; Mice; Oxidative Stress; Parkinson Disease; Pyrimidines; Superoxide Dismutase; Thiourea; Urea | 2009 |
Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 8-Hydroxy-2'-Deoxyguanosine; alpha-Synuclein; Analysis of Variance; Animals; Chromatography, High Pressure Liquid; Creatine; Deoxyguanosine; Disease Models, Animal; Dopamine; Drug Therapy, Combination; Glutathione; Glutathione Disulfide; Huntington Disease; Lipid Peroxidation; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Nitro Compounds; Parkinson Disease; Propionates; Rats; Rats, Inbred Lew; Tyrosine 3-Monooxygenase; Ubiquinone | 2009 |
Effects of pergolide mesilate on metallothionein mRNAs expression in a mouse model for Parkinson disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antioxidants; Brain; Disease Models, Animal; Dopamine Agonists; Gene Expression; Lipid Peroxidation; Malondialdehyde; Metallothionein; Mice; Mice, Inbred C57BL; Parkinson Disease; Pergolide; RNA, Messenger | 2009 |
Potentiation of methamphetamine neurotoxicity by intrastriatal lipopolysaccharide administration.
Topics: Aldehydes; Animals; Blotting, Western; Chromatography, High Pressure Liquid; Corpus Striatum; Drug Synergism; Lipopolysaccharides; Male; Malondialdehyde; Methamphetamine; Mice; Mice, Inbred C57BL; Motor Activity; Parkinson Disease | 2010 |
Involvement of the cerebral cortex in Parkinson disease linked with G2019S LRRK2 mutation without cognitive impairment.
Topics: Aged; Aged, 80 and over; alpha-Synuclein; Cerebral Cortex; Cognition Disorders; Electrophoresis, Gel, Two-Dimensional; Female; Glial Fibrillary Acidic Protein; Glycine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Malondialdehyde; Mass Spectrometry; Mutation; Parkinson Disease; Protein Serine-Threonine Kinases; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Serine; Statistics, Nonparametric | 2010 |
Antioxidative and anti-inflammatory protection from carnosine in the striatum of MPTP-treated mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Inflammatory Agents; Antioxidants; Carnosine; Corpus Striatum; Glutathione; Humans; Interleukin-6; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Nitric Oxide Synthase Type II; Parkinson Disease; Tumor Necrosis Factor-alpha | 2010 |
Protective effect of effective part of Acanthopanacis senticosus on damage of PC12 cells induced by MPP+.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Apoptosis; Araliaceae; Cell Survival; Disease Models, Animal; Drugs, Chinese Herbal; Humans; Malondialdehyde; Neurons; Neuroprotective Agents; Nitric Oxide; Parkinson Disease; PC12 Cells; Rats | 2010 |
Neuroprotective effect of kaempferol against a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antioxidants; Ataxia; Corpus Striatum; Disease Models, Animal; Dopamine; Glutathione Peroxidase; Kaempferols; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neurons; Neuroprotective Agents; Parkinson Disease; Phytotherapy; Plant Extracts; Superoxide Dismutase | 2011 |
Evidence of oxidative stress in the neocortex in incidental Lewy body disease.
Topics: Aged; Aged, 80 and over; Aldehydes; alpha-Synuclein; Blotting, Western; Docosahexaenoic Acids; Electrophoresis, Gel, Two-Dimensional; Fatty Acids; Female; Glycation End Products, Advanced; Humans; Immunohistochemistry; Lewy Body Disease; Male; Malondialdehyde; Mass Spectrometry; Neocortex; Nerve Tissue Proteins; Oxidative Stress; Parkinson Disease; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Synucleins | 2005 |
Nitrite and malondialdehyde content in cerebrospinal fluid of patients with Parkinson's disease.
Topics: Female; Free Radicals; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Nitrates; Nitric Oxide; Nitrites; Oxidative Stress; Parkinson Disease; Severity of Illness Index | 2006 |
Plasma lipid peroxidation and antioxidant status of Parkinson's disease patients in the Indian population.
Topics: Antioxidants; Female; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Humans; India; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Parkinson Disease; Sulfhydryl Compounds; Superoxide Dismutase | 2008 |
[Effects of scalp catgut embedding on SOD, NO, MDA in the rat with Parkinson's disease].
Topics: Acupuncture Therapy; Animals; Catgut; Female; Male; Malondialdehyde; Nitric Oxide; Parkinson Disease; Rats; Rats, Wistar; Scalp; Superoxide Dismutase | 2007 |
Endogenous dopamine (DA) renders dopaminergic cells vulnerable to challenge of proteasome inhibitor MG132.
Topics: alpha-Methyltyrosine; Animals; Cell Survival; Cysteine Proteinase Inhibitors; Dopamine; Leupeptins; Malondialdehyde; Mice; Neurodegenerative Diseases; Neurons; Parkinson Disease; PC12 Cells; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Rats; Tetrazolium Salts; Thiazoles | 2008 |
Iron contributes to the formation of catechol isoquinolines and oxidative toxicity induced by overdose dopamine in dopaminergic SH-SY5Y cells.
Topics: Apoptosis; Catechols; Cell Line, Tumor; Cell Survival; Dopamine; Dose-Response Relationship, Drug; Humans; Hydroxyl Radical; Iron; Iron Metabolism Disorders; Isoquinolines; Malondialdehyde; Models, Biological; Nerve Degeneration; Neurons; Neurotoxins; Oxidative Stress; Parkinson Disease; Salsoline Alkaloids; Up-Regulation | 2008 |
Iron induced oxidative stress and mitochondrial dysfunction: relevance to Parkinson's disease.
Topics: Animals; Electron Transport; Glutathione; Iron; Malondialdehyde; Mitochondria; Oxidation-Reduction; Parkinson Disease; PC12 Cells; Substantia Nigra | 1993 |
No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Antiparkinson Agents; Brain; Cabergoline; Carbidopa; Diabetes Mellitus; Ergolines; Female; Free Radicals; Humans; Levodopa; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Parkinson Disease; Selegiline; Vitamin E | 1995 |
Levodopa and deprenyl treatment effects on peripheral indices of oxidant stress in Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Aged, 80 and over; Cysteinyldopa; Humans; Levodopa; Malondialdehyde; Methoxyhydroxyphenylglycol; Middle Aged; Oxidative Stress; Parkinson Disease; Selegiline | 1996 |
Oxygen free radical producing activity of polymorphonuclear leukocytes in patients with Parkinson's disease.
Topics: Aged; Female; Free Radicals; Humans; Luminescent Measurements; Male; Malondialdehyde; Middle Aged; Neutrophils; Parkinson Disease; Superoxides | 1992 |
Serum lipid peroxides in patients with Parkinson's disease.
Topics: Aged; Female; Humans; Lipid Peroxides; Male; Malondialdehyde; Parkinson Disease; Risk Factors | 1992 |
Lipid peroxidation as cause of nigral cell death in Parkinson's disease.
Topics: Aged; Brain Chemistry; Cell Survival; Fatty Acids, Unsaturated; Humans; Lipid Peroxides; Malondialdehyde; Middle Aged; Parkinson Disease; Substantia Nigra | 1986 |
Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease.
Topics: Aged; Animals; Ascorbic Acid; Brain; Fatty Acids, Unsaturated; Female; Ferrous Compounds; Free Radicals; Humans; Hydrogen Peroxide; Lipid Peroxidation; Male; Malondialdehyde; Parkinson Disease; Postmortem Changes; Rats; Rats, Inbred Strains; Substantia Nigra; Thiobarbiturates | 1989 |